ACE and Cirrhosis: Although our present findings cannot explain this conflict, Ho et al. [24] found that the use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers was associated with higher HCC occurrence in patient subgroups consisting of patients with no cirrhosis, no DM, and no hyperlipidemia.